Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Ozempic often causes about 20 to 30 percent of total weight loss to come from lean mass, which can impact strength, metabolism and long-term health. Whether you should switch medications depends on how much muscle you are losing, how it affects your daily function and your overall diabetes and weight management goals.
See below for key clinical data, alternative medication options and targeted nutrition and exercise strategies that can influence your decision.
Ozempic (semaglutide) has become a leading prescription for type 2 diabetes and weight management. Many people see steady, sustainable weight loss—but some also notice a reduction in muscle mass. If you've been asking, "why does Ozempic cause muscle loss?" you're not alone. This article unpacks the science behind lean-tissue changes, offers practical tips to maintain muscle, and helps you decide if switching meds is right for you.
When you lose weight, your body sheds two main components:
Clinical trials show that about 20–30% of weight lost on GLP-1 agonists like Ozempic can be lean mass. This isn't unique to semaglutide; most diets and calorie-restriction plans produce a similar ratio. However, muscle loss can have implications for strength, metabolism and long-term health.
Ozempic doesn't directly "attack" muscle cells. Instead, muscle changes stem from the overall weight-loss process:
Calorie Deficit
Hormonal and Metabolic Shifts
Physical Activity Changes
Multiple studies have investigated body composition changes with semaglutide:
STEP Trials (Weight Management)
• Participants lost 10–15% of body weight in 68 weeks.
• Lean mass comprised roughly 25% of total weight loss.
• Fat mass reduction was about three-quarters of total loss.
SUSTAIN Trials (Diabetes Control)
• Significant HbA1c reduction with moderate weight loss.
• Lean mass changes mirrored those in weight-management trials.
Comparisons vs. Lifestyle Alone
• Diet and exercise alone often produce 20–30% lean-mass loss during rapid weight reduction.
• Adding resistance training can shift losses toward fat, preserving muscle.
These data confirm that some muscle loss is expected when dropping weight on Ozempic. The key is minimizing it to protect strength and metabolic rate.
Deciding whether to switch medications depends on individual goals, side effects and health status. Consider these factors:
Degree of Muscle Loss
• Mild reductions are common and reversible.
• Significant weakness, functional decline or sarcopenia (age-related muscle loss) warrants closer evaluation.
Alternative GLP-1 Agonists
• Trulicity (dulaglutide) and Rybelsus (oral semaglutide) have similar profiles.
• Lean-mass changes are comparable across this class.
Non-GLP-1 Options
• SGLT2 inhibitors (e.g., Jardiance) for diabetes—minimal direct appetite effect, less weight loss.
• Orlistat blocks fat absorption—modest weight loss, minimal muscle changes.
• Older appetite suppressants (phentermine) or combination therapies—different mechanisms, varied side effects.
Risk vs. Benefit
• For diabetes control, cardiovascular benefit and steady weight loss, GLP-1s often top the list.
• If muscle loss significantly impairs daily life, discuss dose adjustment or a med switch with your doctor.
Switching is not the only solution. Often, targeted lifestyle changes and monitoring can preserve muscle while you keep the metabolic benefits of Ozempic.
Whether you stay on Ozempic or switch, here's how to protect lean mass:
Boost Protein Intake
• Aim for 1.2–1.6 g of protein per kilogram of body weight daily.
• Include lean meats, dairy, eggs, legumes, or plant-based proteins at each meal.
Engage in Resistance Training
• 2–4 times per week: bodyweight exercises, free weights or machines.
• Focus on major muscle groups—legs, back, chest, shoulders.
Incorporate High-Intensity Interval Training (HIIT)
• Short bursts of intense effort help maintain muscle.
• Protects metabolic rate better than steady-state cardio alone.
Ensure Adequate Recovery
• 7–9 hours of quality sleep per night aids muscle repair.
• Manage stress—high cortisol can promote muscle breakdown.
Consider Protein Supplementation
• Whey or plant-based protein powders can help reach targets.
• Consume post-workout to maximize muscle protein synthesis.
Regular Body Composition Monitoring
• Scale weight alone doesn't tell the whole story.
• Use DEXA scans, bioelectrical impedance or circumference measurements to track lean vs. fat mass.
Losing a bit of muscle may be par for the course, but watch for red-flag signs:
If you experience any of these concerning symptoms while taking Ozempic, you can quickly assess your situation using a Medically approved LLM Symptom Checker Chat Bot to help determine whether you need immediate medical attention or can safely wait for your next scheduled appointment.
Always discuss any serious or life-threatening concerns with a qualified healthcare professional. A physician can:
Ozempic remains a powerful tool for diabetes management and weight loss. Some muscle loss is expected due to calorie restriction and metabolic shifts—this answers "why does Ozempic cause muscle loss." However, with targeted nutrition, strength training and regular monitoring, you can minimize lean-mass decline. Switching meds is not always necessary, but it's an option if muscle loss significantly affects your daily life. If in doubt, consult a Medically approved AI Symptom Checker or speak with your doctor to make the safest, most effective choice.
(References)
* Aaronson, M., & Apovian, C. M. (2024). Semaglutide and lean mass loss: a systematic review and meta-analysis of randomized controlled trials. *Obesity Reviews, 25*(2), e13661.
* Cai, X., Cai, X., Zhou, Y., & Wei, X. (2022). Body Composition Changes With Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis. *Frontiers in Endocrinology, 13*, 1069695.
* Hadjiyanni, E. V., Stasinou, M., Papagianni, M., Papanas, N., & Roka, V. (2023). Sarcopenia in Patients Receiving GLP-1 Receptor Agonists: A Scoping Review. *Nutrients, 15*(23), 4983.
* Tsimogianni, A. M., Koliaki, C., Georgilis, G., Kokkinos, A., Kyriazi, A., & Tentolouris, N. (2023). Changes in body composition and metabolic parameters after 12 months of semaglutide treatment in obese patients with type 2 diabetes mellitus. *Diabetology & Metabolic Syndrome, 15*(1), 162.
* Park, S. H., Park, J. M., Rhee, E. J., Park, S. E., & Kim, S. W. (2023). Effect of semaglutide on body composition in patients with obesity and type 2 diabetes: a retrospective study. *Endocrine, 81*(1), 77–84.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.